日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FDA Approval Summary: Olutasidenib for Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase 1 Mutation

FDA批准摘要:奥鲁西地尼用于治疗伴有异柠檬酸脱氢酶1突变的复发或难治性急性髓系白血病成人患者

Woods, Ashley C; Norsworthy, Kelly J; Choe, Moran; Gehrke, Brenda J; Chen, Haiyan; Vallejo, Jonathon; Pan, Lili; Jiang, Xiling; Li, Hongshan; Kraft, Jeffrey; Liu, Jiang; Charlab, Rosane; Okusanya, Olanrewaju O; Booth, Brian; Pazdur, Richard; Theoret, Marc R; Angelo de Claro, R

FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy

FDA批准摘要:Blinatumomab用于多阶段化疗巩固期治疗B细胞前体急性淋巴细胞白血病

Rabik, Cara A; Wang, Shu; Chadda, Ritu; Przepiorka, Donna; Vallejo, Jonathon; Jiang, Xiling; Theoret, Marc R; de Claro, R Angelo

FDA Approval Summary: Ivosidenib in Combination with Azacitidine for Treatment of Patients with Newly Diagnosed Acute Myeloid Leukemia with an IDH1 Mutation

FDA批准摘要:伊沃西尼联合阿扎胞苷治疗新诊断的伴有IDH1突变的急性髓系白血病患者

Woods, Ashley; Norsworthy, Kelly J; Wang, Xin; Vallejo, Jonathon; Chiu Yuen Chow, Edwin; Li, Ruo-Jing; Sun, Jielin; Charlab, Rosane; Jiang, Xiling; Pazdur, Richard; Theoret, Marc R; de Claro, R Angelo

Gut microbiota and oral cavity cancer: a two-sample bidirectional Mendelian randomization study

肠道菌群与口腔癌:一项双样本双向孟德尔随机化研究

Sun, Zhijuan; Bai, Chunying; Hao, Dandan; Jiang, Xiling; Chen, Jianxing

Altered intestinal microbiota enhances adenoid hypertrophy by disrupting the immune balance

肠道菌群失调通过破坏免疫平衡促进腺样体肥大。

Wenxin Liu ,Huier Jiang ,Xiling Liu ,Yue Zheng ,Yanan Liu ,Fen Pan ,Fangyuan Yu ,Zhi Li ,Meizhen Gu ,Qingqing Du ,Xiaoyan Li ,Hong Zhang ,Dingding Han

Anterior cerebral falx plane in MR images to estimate the craniofacial midline

利用磁共振图像中的大脑前镰平面来估计颅面中线

Pei, Jun; Liao, Xu; Ge, Lingling; Liu, Jianwei; Jiang, Xiling

Anatomical network modules of the human central nervous-craniofacial skeleton system

人类中枢神经-颅面骨骼系统的解剖网络模块

Qing, Gele; Jia, Fucang; Liu, Jianwei; Jiang, Xiling

Comprehensive Analysis of the Oncogenic Role of Targeting Protein for Xklp2 (TPX2) in Human Malignancies

对靶向Xklp2蛋白(TPX2)在人类恶性肿瘤中的致癌作用进行全面分析

Shao, Ting; Jiang, Xiling; Bao, Guochang; Li, Chunsheng; Guo, Changgang

FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer

FDA批准摘要:Alpelisib联合Fulvestrant用于治疗HR阳性、HER2阴性、PIK3CA突变的晚期或转移性乳腺癌患者

Narayan, Preeti; Prowell, Tatiana M; Gao, Jennifer J; Fernandes, Laura L; Li, Emily; Jiang, Xiling; Qiu, Junshan; Fan, Jianghong; Song, Pengfei; Yu, Jingyu; Zhang, Xinyuan; King-Kallimanis, Bellinda L; Chen, Wei; Ricks, Tiffany K; Gong, Yutao; Wang, Xing; Windsor, Katherine; Rhieu, Steve Y; Geiser, Gerlie; Banerjee, Anamitro; Chen, Xiaohong; Reyes Turcu, Francisca; Chatterjee, Deb K; Pathak, Anand; Seidman, Jeffrey; Ghosh, Soma; Philip, Reena; Goldberg, Kirsten B; Kluetz, Paul G; Tang, Shenghui; Amiri-Kordestani, Laleh; Theoret, Marc R; Pazdur, Richard; Beaver, Julia A

Benefit-Risk Summary of Nivolumab for the Treatment of Patients with Unresectable Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma After Prior Fluoropyrimidine- and Platinum-Based Chemotherapy

纳武利尤单抗治疗既往接受过氟尿嘧啶和铂类化疗的不可切除的晚期、复发性或转移性食管鳞状细胞癌患者的获益风险总结

Pelosof, Lorraine; Saung, May Tun; Donoghue, Martha; Casak, Sandra; Mushti, Sirisha; Cheng, Joyce; Jiang, Xiling; Liu, Jiang; Zhao, Hong; Khazraee, Maryam; Goldberg, Kirsten B; Theoret, Marc; Lemery, Steven; Pazdur, Richard; Fashoyin-Aje, Lola